A Pilot Study of Multi-Input Recurrent Neural Networks for Drug-Kinase Binding Prediction

The use of virtual drug screening can be beneficial to research teams, enabling them to narrow down potentially useful compounds for further study. A variety of virtual screening methods have been developed, typically with machine learning classifiers at the center of their design. In the present st...

Full description

Bibliographic Details
Main Authors: Kristy Carpenter, Alexander Pilozzi, Xudong Huang
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/25/15/3372
id doaj-1bc3a02952e94fafa9598ffabe9cf0d3
record_format Article
spelling doaj-1bc3a02952e94fafa9598ffabe9cf0d32020-11-25T03:02:15ZengMDPI AGMolecules1420-30492020-07-01253372337210.3390/molecules25153372A Pilot Study of Multi-Input Recurrent Neural Networks for Drug-Kinase Binding PredictionKristy Carpenter0Alexander Pilozzi1Xudong Huang2Neurochemistry Laboratory, Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129, USANeurochemistry Laboratory, Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129, USANeurochemistry Laboratory, Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129, USAThe use of virtual drug screening can be beneficial to research teams, enabling them to narrow down potentially useful compounds for further study. A variety of virtual screening methods have been developed, typically with machine learning classifiers at the center of their design. In the present study, we created a virtual screener for protein kinase inhibitors. Experimental compound–target interaction data were obtained from the IDG-DREAM Drug-Kinase Binding Prediction Challenge. These data were converted and fed as inputs into two multi-input recurrent neural networks (RNNs). The first network utilized data encoded in one-hot representation, while the other incorporated embedding layers. The models were developed in Python, and were designed to output the IC<sub>50</sub><i> </i>of the target compounds.<i> </i>The performance of the models was assessed primarily through analysis of the Q<sup>2</sup> values produced from runs of differing sample and epoch size; recorded loss values were also reported and graphed. The performance of the models was limited, though multiple changes are proposed for potential improvement of a multi-input recurrent neural network-based screening tool.https://www.mdpi.com/1420-3049/25/15/3372artificial intelligence (AI)machine learning (ML)deep learning (DL)recurrent neural network (RNN), virtual drug screening
collection DOAJ
language English
format Article
sources DOAJ
author Kristy Carpenter
Alexander Pilozzi
Xudong Huang
spellingShingle Kristy Carpenter
Alexander Pilozzi
Xudong Huang
A Pilot Study of Multi-Input Recurrent Neural Networks for Drug-Kinase Binding Prediction
Molecules
artificial intelligence (AI)
machine learning (ML)
deep learning (DL)
recurrent neural network (RNN), virtual drug screening
author_facet Kristy Carpenter
Alexander Pilozzi
Xudong Huang
author_sort Kristy Carpenter
title A Pilot Study of Multi-Input Recurrent Neural Networks for Drug-Kinase Binding Prediction
title_short A Pilot Study of Multi-Input Recurrent Neural Networks for Drug-Kinase Binding Prediction
title_full A Pilot Study of Multi-Input Recurrent Neural Networks for Drug-Kinase Binding Prediction
title_fullStr A Pilot Study of Multi-Input Recurrent Neural Networks for Drug-Kinase Binding Prediction
title_full_unstemmed A Pilot Study of Multi-Input Recurrent Neural Networks for Drug-Kinase Binding Prediction
title_sort pilot study of multi-input recurrent neural networks for drug-kinase binding prediction
publisher MDPI AG
series Molecules
issn 1420-3049
publishDate 2020-07-01
description The use of virtual drug screening can be beneficial to research teams, enabling them to narrow down potentially useful compounds for further study. A variety of virtual screening methods have been developed, typically with machine learning classifiers at the center of their design. In the present study, we created a virtual screener for protein kinase inhibitors. Experimental compound–target interaction data were obtained from the IDG-DREAM Drug-Kinase Binding Prediction Challenge. These data were converted and fed as inputs into two multi-input recurrent neural networks (RNNs). The first network utilized data encoded in one-hot representation, while the other incorporated embedding layers. The models were developed in Python, and were designed to output the IC<sub>50</sub><i> </i>of the target compounds.<i> </i>The performance of the models was assessed primarily through analysis of the Q<sup>2</sup> values produced from runs of differing sample and epoch size; recorded loss values were also reported and graphed. The performance of the models was limited, though multiple changes are proposed for potential improvement of a multi-input recurrent neural network-based screening tool.
topic artificial intelligence (AI)
machine learning (ML)
deep learning (DL)
recurrent neural network (RNN), virtual drug screening
url https://www.mdpi.com/1420-3049/25/15/3372
work_keys_str_mv AT kristycarpenter apilotstudyofmultiinputrecurrentneuralnetworksfordrugkinasebindingprediction
AT alexanderpilozzi apilotstudyofmultiinputrecurrentneuralnetworksfordrugkinasebindingprediction
AT xudonghuang apilotstudyofmultiinputrecurrentneuralnetworksfordrugkinasebindingprediction
AT kristycarpenter pilotstudyofmultiinputrecurrentneuralnetworksfordrugkinasebindingprediction
AT alexanderpilozzi pilotstudyofmultiinputrecurrentneuralnetworksfordrugkinasebindingprediction
AT xudonghuang pilotstudyofmultiinputrecurrentneuralnetworksfordrugkinasebindingprediction
_version_ 1724690580983775232